Interaction of metals with prion protein: Possible role of divalent cations in the pathogenesis of prion diseases

NeuroToxicology

Volumn 27, Issue 5, 2006, Pages 777-787

  Choi, Christopher J ^a   Kanthasamy, Arthi ^a   Anantharam, Vellareddy ^a   Kanthasamy, Anumantha G ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Copper; Iron; Manganese; Metals; Neurotoxicity; PrP; Scrapie; Transmissible spongiform encephalopathy

Indexed keywords

COPPER; CYANIDE; DIVALENT CATION; IRON; MANGANESE; METAL; OCTAPEPTIDE; PRION PROTEIN; TRANSITION ELEMENT; ZINC;

ANTIOXIDANT ACTIVITY; ARTICLE; BINDING AFFINITY; CONFORMATIONAL TRANSITION; DISEASE EXACERBATION; HUMAN; METAL BINDING; OXIDATIVE STRESS; PATHOGENESIS; PHYSIOLOGY; PRION DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; SCRAPIE;

ANIMALS; HUMANS; METALS; PRION DISEASES; PRIONS;

ANIMALIA; MAMMALIA; SCRAPIE PRION;

EID: 33747164172     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2006.06.004     Document Type: Article

References (158)

1. Anantharam V., Vorberg I., Choi C.J., Kanthasamy A., Richt J.A., Priola S.A., et al. Proteolytic activation of PKCdelta contributes to oxidative- and ER-stress induced apoptotic cell death in prion-overexpressing mouse neural cells. Proceedings of the 34th Annual Meeting of the Society for Neuroscience (2004) [Abstract]
2. 2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochemistry 39 (2000) 13760-13771
3. Aust S.D., Morehouse L.A., and Thomas C.E. Role of metals in oxygen radical reactions. J Free Radic Biol Med 1 (1985) 3-25
4. Bailey C.H., Kandel E.R., and Si K. The persistence of long-term memory: a molecular approach to self-sustaining changes in learning-induced synaptic growth. Neuron 44 (2004) 49-57
5. Barcikowska M., Liberski P.P., Boellaard J.W., Brown P., Gajdusek D.C., and Budka H. Microglia is a component of the prion protein amyloid plaque in the Gerstmann-Straussler-Scheinker syndrome. Acta Neuropathol (Berl) 85 (1993) 623-627
6. Baringer J.R., Bowman K.A., and Prusiner SB. Replication of the scrapie agent in hamster brain precedes neuronal vacuolation. J Neuropathol Exp Neurol 42 (1983) 539-547
7. Blakemore W.F. Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J Neurocytol 1 (1972) 413-426
8. Bocharova O.V., Breydo L., Salnikov V.V., and Baskakov I.V. Copper (II) inhibits in vitro conversion of prion protein into amyloid fibrils. Biochemistry 44 (2005) 6776-6787
9. Brotherston J.G., Renwick C.C., Stamp J.T., Zlotnik I., and Pattison I.H. Spread and scrapie by contact to goats and sheep. J Comp Pathol 78 (1968) 9-17
10. Brown D.R. Prion protein expression modulates neuronal copper content. J Neurochem 87 (2003) 377-385
11. Brown D.R., and Besinger A. A prion protein expression and superoxide dismutase activity. Biochem J 334 Pt 2 (1998) 423-429
12. Brown D.R., and Harris D.A. Copper and zinc cause delivery of the prion protein from the plasma membrane to a subset of early endosomes and the Golgi. J Neurochem 87 (2003) 353-363
13. Brown D.R., Schulz-Schaeffer W.J., Schmidt B., and Kretzschmar H.A. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol 146 (1997) 104-112
14. Brown D.R., Qin K., Herms J.W., Madlung A., Manson J., Strome R., et al. The cellular prion protein binds copper in vivo. Nature 390 (1997) 684-687
15. Brown D.R., Schmidt B., and Kretzschmar H.A. Effects of copper on survival of prion protein knockout neurons and glia. J Neurochem 70 (1998) 1686-1693
16. Brown D.R., Hafiz F., Glasssmith L.L., Wong B.S., Jones I.M., Clive C., et al. Consequences of manganese replacement of copper for prion protein function and proteinase resistance. EMBO J 19 (2000) 1180-1186
17. Brown D.R., Clive C., and Haswell S.J. Antioxidant activity related to copper binding of native prion protein. J Neurochem 76 (2001) 69-76
18. Brown D.R., Nicholas R.S., and Canevari L. Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J Neurosci Res 67 (2002) 211-224
19. Brown P. Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy. Vox Sang 89 (2005) 63-70
20. Brown P. Pathogenesis and transfusion risk of transmissible spongiform encephalopathies. Dev Biol (Basel) 120 (2005) 27-33
21. Brown P., and Gajdusek D.C. The human spongiform encephalopathies: kuru, Creutzfeldt-Jakob disease, and the Gerstmann-Straussler-Scheinker syndrome. Curr Top Microbiol Immunol 172 (1991) 1-20
22. Budka H., Aguzzi A., Brown P., Brucher J.M., Bugiani O., Gullotta F., et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5 (1995) 459-466
23. Camakaris J., Voskoboinik I., and Mercer J.F. Molecular mechanisms of copper homeostasis. Biochem Biophys Res Commun 261 (1999) 225-232
24. Cereghetti G.M., Schweiger A., Glockshuber R., and Van Doorslaer S. Stability and Cu(II) binding of prion protein variants related to inherited human prion diseases. Biophys J 84 (2003) 1985-1997
25. Chapman J., Arlazoroff A., Goldfarb L.G., Cervenakova L., Neufeld M.Y., Werber E., et al. Fatal insomnia in a case of familial Creutzfeldt-Jakob disease with the codon 200(Lys) mutation. Neurology 46 (1996) 758-761
26. Chatigny M.A., and Prusiner S.B. Biohazards of investigations on the transmissible spongiform encephalopathies. Rev Infect Dis 2 (1980) 713-724
27. Chen S., Mange A., Dong L., Lehmann S., and Schachner M. Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival. Mol Cell Neurosci 22 (2003) 227-233
28. Chiarini L.B., Freitas A.R., Zanata S.M., Brentani R.R., Martins V.R., and Linden R. Cellular prion protein transduces neuroprotective signals. EMBO J 21 (2002) 3317-3326
29. Chihota C.M., Gravenor M.B., and Baylis M. Investigation of trace elements in soil as risk factors in the epidemiology of scrapie. Vet Rec 154 (2004) 809-813
30. Ciechanover A., and Brundin P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40 (2003) 427-446
31. Cohen F.E., Pan K.M., Huang Z., Baldwin M., Fletterick R.J., and Prusiner S.B. Structural clues to prion replication. Science 264 (1994) 530-531
32. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24 (2001) 519-550
33. Collinge J., and Palmer M.S. Prion diseases. Curr Opin Genet Dev 2 (1992) 448-454
34. Collinge J., Harding A.E., Owen F., Poulter M., Lofthouse R., Boughey A.M., et al. Diagnosis of Gerstmann-Straussler syndrome in familial dementia with prion protein gene analysis. Lancet 2 (1989) 15-17
35. Darnell R.B. Memory, synaptic translation, and prions?. Cell 115 (2003) 767-768
36. DeArmond S.J., and Prusiner S.B. Prion protein transgenes and the neuropathology in prion diseases. Brain Pathol 5 (1995) 77-89
37. Deignan M.E., Prior M., Stuart L.E., Comerford E.J., and McMahon H.E. The structure function relationship for the prion protein. J Alzheimers Dis 6 (2004) 283-289
38. Di Natale G., Grasso G., Impellizzeri G., La Mendola D., Micera G., Mihala N., et al. Copper (II) interaction with unstructured prion domain outside the octarepeat region: speciation, stability, and binding details of copper (II) complexes with PrP106-126 peptides. Inorg Chem 44 (2005) 7214-7225
39. Diener T.O., McKinley M.P., and Prusiner S.B. Viroids and prions. Proc Natl Acad Sci USA 79 (1982) 5220-5224
40. Dobson A.W., Erikson K.M., and Aschner M. Manganese neurotoxicity. Ann NY Acad Sci 1012 (2004) 115-128
41. Fernaeus S., and Land T. Increased iron-induced oxidative stress and toxicity in scrapie-infected neuroblastoma cells. Neurosci Lett 382 (2005) 217-220
42. Fernaeus S., Reis K., Bedecs K., and Land T. Increased susceptibility to oxidative stress in scrapie-infected neuroblastoma cells is associated with intracellular iron status. Neurosci Lett 389 (2005) 133-136
43. Fernaeus S., Halldin J., Bedecs K., and Land T. Changed iron regulation in scrapie-infected neuroblastoma cells. Brain Res Mol Brain Res 133 (2005) 266-273
44. Fioriti L., Dossena S., Stewart L.R., Stewart R.S., Harris D.A., Forloni G., et al. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations. J Biol Chem 280 (2005) 11320-11328
45. Flechsig E., Hegyi I., Enari M., Schwarz P., Collinge J., and Weissmann C. Transmission of scrapie by steel-surface-bound prions. Mol Med 7 (2001) 679-684
46. Gaggelli E., Bernardi F., Molteni E., Pogni R., Valensin D., Valensin G., et al. Interaction of the human prion PrP(106-126) sequence with copper (II), manganese (II), and zinc (II): NMR and EPR studies. J Am Chem Soc 127 (2005) 996-1006
47. Gasset M., Baldwin M.A., Fletterick R.J., and Prusiner S.B. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc Natl Acad Sci USA 90 (1993) 1-5
48. Giaccone G., Verga L., Bugiani O., Frangione B., Serban D., Prusiner S.B., et al. Prion protein preamyloid and amyloid deposits in Gerstmann-Straussler-Scheinker disease, Indiana kindred. Proc Natl Acad Sci USA 89 (1992) 9349-9353
49. Gibbs Jr. C.J., Joy A., Heffner R., Franko M., Miyazaki M., Asher D.M., et al. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. New Engl J Med 313 (1985) 734-738
50. Giese A., Buchholz M., Herms J., and Kretzschmar H.A. Mouse brain synaptosomes accumulate copper-67 efficiently by two distinct processes independent of cellular prion protein. J Mol Neurosci 27 (2005) 347-354
51. Goldgaber D., Goldfarb L.G., Brown P., Asher D.M., Brown W.T., Lin S., et al. Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker's syndrome. Exp Neurol 106 (1989) 204-206
52. Guiroy D.C., Williams E.S., Song K.J., Yanagihara R., and Gajdusek D.C. Fibrils in brain of Rocky Mountain elk with chronic wasting disease contain scrapie amyloid. Acta Neuropathol (Berl) 86 (1993) 77-80
53. Haigh C.L., Edwards K., and Brown D.R. Copper binding is the governing determinant of prion protein turnover. Mol Cell Neurosci 30 (2005) 186-196
54. Hainfellner J.A., Liberski P.P., Guiroy D.C., Cervenakova L., Brown P., Gajdusek D.C., et al. Pathology and immunocytochemistry of a kuru brain. Brain Pathol 7 (1997) 547-553
55. Haltia M., Kovanen J., Goldfarb L.G., Brown P., and Gajdusek D.C. Familial Creutzfeldt-Jakob disease in Finland: epidemiological, clinical, pathological and molecular genetic studies. Eur J Epidemiol 7 (1991) 494-500
56. Hamir A.N., Miller J.M., Cutlip R.C., Kunkle R.A., Jenny A.L., Stack M.J., et al. Transmission of sheep scrapie to elk (Cervus elaphus nelsoni) by intracerebral inoculation: final outcome of the experiment. J Vet Diagn Invest 16 (2004) 316-321
57. Hamir A.N., Kunkle R.A., Cutlip R.C., Miller J.M., O'Rourke K.I., Williams E.S., et al. Experimental transmission of chronic wasting disease agent from mule deer to cattle by the intracerebral route. J Vet Diagn Invest 17 (2005) 276-281
58. Herms J., Tings T., Gall S., Madlung A., Giese A., Siebert H., et al. Evidence of presynaptic location and function of the prion protein. J Neurosci 19 (1999) 8866-8875
59. Hijazi N., Shaked Y., Rosenmann H., Ben-Hur T., and Gabizon R. Copper binding to PrPC may inhibit prion disease propagation. Brain Res 993 (2003) 192-200
60. Hill A.F., and Collinge J. Subclinical prion infection in humans and animals. Br Med Bull 66 (2003) 161-170
61. Hill A.F., Butterworth R.J., Joiner S., Jackson G., Rossor M.N., Thomas D.J., et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353 (1999) 183-189
62. Hill A.F., Joiner S., Linehan J., Desbruslais M., Lantos P.L., and Collinge J. Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci USA 97 (2000) 10248-10253
63. Hogan R.N., Brown P., Heck E., and Cavanagh H.D. Risk of prion disease transmission from ocular donor tissue transplantation. Cornea 18 (1999) 2-11
64. Horiuchi M., Priola S.A., Chabry J., and Caughey B. Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers. Proc Natl Acad Sci USA 97 (2000) 5836-5841
65. Hornshaw M.P., McDermott J.R., Candy J.M., and Lakey J.H. Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem Biophys Res Commun 214 (1995) 993-999
66. Hsiao K., and Prusiner S.B. Molecular genetics and transgenic model of Gerstmann-Straussler-Scheinker disease. Alzheimer Dis Assoc Disord 5 (1991) 155-162
67. Hsiao K., Baker H.F., Crow T.J., Poulter M., Owen F., Terwilliger J.D., et al. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338 (1989) 342-345
68. Hsiao K., Dlouhy S.R., Farlow M.R., Cass C., Da Costa M., Conneally P.M., et al. Mutant prion proteins in Gerstmann-Straussler-Scheinker disease with neurofibrillary tangles. Nat Genet 1 (1992) 68-71
69. Huang Z., Prusiner S.B., and Cohen F.E. Scrapie prions: a three-dimensional model of an infectious fragment. Fold Des 1 (1996) 13-19
70. Huang Z., Prusiner S.B., and Cohen F.E. Structures of prion proteins and conformational models for prion diseases. Curr Top Microbiol Immunol 207 (1996) 49-67
71. Hutter G., Heppner F.L., and Aguzzi A. No superoxide dismutase activity of cellular prion protein in vivo. Biol Chem 384 (2003) 1279-1285
72. Jackson G.S., Murray I., Hosszu L.L., Gibbs N., Waltho J.P., Clarke A.R., et al. Location and properties of metal-binding sites on the human prion protein. Proc Natl Acad Sci USA 98 (2001) 8531-8535
73. Jobling M.F., Huang X., Stewart L.R., Barnham K.J., Curtain C., Volitakis I., et al. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126. Biochemistry 40 (2001) 8073-8084
74. 2+ coordination by His96 and His111 induces beta-sheet formation in the unstructured amyloidogenic region of the prion protein. J Biol Chem 279 (2004) 32018-32027
75. 1H NMR: the unstructured N terminus facilitates the coordination of six copper 2+ ions at physiological concentrations. J Mol Biol 346 (2005) 1393-1407
76. Jones S., Batchelor M., Bhelt D., Clarke A.R., Collinge J., and Jackson G.S. Recombinant prion protein does not possess superoxide dismutase activity. Biochem J (2005)
77. Kaneko K., Wille H., Mehlhorn I., Zhang H., Ball H., Cohen F.E., et al. Molecular properties of complexes formed between the prion protein and synthetic peptides. J Mol Biol 270 (1997) 574-586
78. Kang S.C., Brown D.R., Whiteman M., Li R., Pan T., Perry G., et al. Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice. J Pathol 203 (2004) 603-608
79. Kim N.H., Choi J.K., Jeong B.H., Kim J.I., Kwon M.S., Carp R.I., et al. Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres. FASEB J 19 (2005) 783-785
80. Kimberlin R.H., and Millson G.C. The effects of cuprizone toxicity on the incubation period of scrapie in mice. J Comp Pathol 86 (1976) 489-496
81. Kuczius T., Buschmann A., Zhang W., Karch H., Becker K., Peters G., et al. Cellular prion protein acquires resistance to proteolytic degradation following copper ion binding. Biol Chem 385 (2004) 739-747
82. Lasmezas C.I. Putative functions of PrP(C). Br Med Bull 66 (2003) 61-70
83. Laszlo L., Lowe J., Self T., Kenward N., Landon M., McBride T., et al. Lysosomes as key organelles in the pathogenesis of prion encephalopathies. J Pathol 166 (1992) 333-341
84. Legname G., Nguyen H.O., Baskakov I.V., Cohen F.E., Dearmond S.J., and Prusiner S.B. Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci USA 102 (2005) 2168-2173
85. Levin J., Bertsch U., Kretzschmar H., and Giese A. Single particle analysis of manganese-induced prion protein aggregates. Biochem Biophys Res Commun 329 (2005) 1200-1207
86. Liberski P.P., and Brown P. Kuru: a half-opened window onto the landscape of neurodegenerative diseases. Folia Neuropathol 42 Suppl. A (2004) 3-14
87. Liberski P.P., Kwiecinski H., Barcikowska M., Mirecka B., Kulczycki J., Kida E., et al. Creutzfeldt-Jakob disease (CJD) of a short duration with prion protein (PrP) plaques. Patol Pol 42 (1991) 115-118
88. Ma J., Wollmann R., and Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298 (2002) 1781-1785
89. Martins V.R., and Brentani R.R. The biology of the cellular prion protein. Neurochem Int 41 (2002) 353-355
90. Martins V.R., Mercadante A.F., Cabral A.L., Freitas A.R., and Castro R.M. Insights into the physiological function of cellular prion protein. Braz J Med Biol Res 34 (2001) 585-595
91. McKinley M.P., and Prusiner S.B. Biology and structure of scrapie prions. Int Rev Neurobiol 28 (1986) 1-57
92. Mishra R.S., Basu S., Gu Y., Luo X., Zou W.Q., Mishra R., et al. Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J Neurosci 24 (2004) 11280-11290
93. Miura T., Sasaki S., Toyama A., and Takeuchi H. Copper reduction by the octapeptide repeat region of prion protein: pH dependence and implications in cellular copper uptake. Biochemistry 44 (2005) 8712-8720
94. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J.L., Lehmann S., Launay J.M., et al. Signal transduction through prion protein. Science 289 (2000) 1925-1928
95. Muller H., Strom A., Hunsmann G., and Stuke A.W. Separation of native prion protein (PrP) glycoforms by copper-binding using immobilized metal affinity chromatography (IMAC). Biochem J 388 (2005) 371-378
96. Nguyen J., Baldwin M.A., Cohen F.E., and Prusiner S.B. Prion protein peptides induce alpha-helix to beta-sheet conformational transitions. Biochemistry 34 (1995) 4186-4192
97. Nishimura T., Sakudo A., Nakamura I., Lee D.C., Taniuchi Y., Saeki K., et al. Cellular prion protein regulates intracellular hydrogen peroxide level and prevents copper-induced apoptosis. Biochem Biophys Res Commun 323 (2004) 218-222
98. Nishina K., Jenks S., and Supattapone S. Ionic strength and transition metals control PrPSc protease resistance and conversion-inducing activity. J Biol Chem 279 (2004) 40788-40794
99. O'Dell B.L. Biochemistry of copper. Med Clin North Am 60 (1976) 687-703
100. Opazo C., Barria M.I., Ruiz F.H., and Inestrosa N.C. Copper reduction by copper binding proteins and its relation to neurodegenerative diseases. Biometals 16 (2003) 91-98
101. Owen F., Poulter M., Lofthouse R., Collinge J., Crow T.J., Risby D., et al. Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet 1 (1989) 51-52
102. Palmer M.S., and Collinge J. Human prion diseases. Curr Opin Neurol Neurosurg 5 (1992) 895-901
103. Palmer M.S., Mahal S.P., Campbell T.A., Hill A.F., Sidle K.C., Laplanche J.L., et al. Deletions in the prion protein gene are not associated with CJD. Hum Mol Genet 2 (1993) 541-544
104. Papassotiropoulos A., Wollmer M.A., Aguzzi A., Hock C., Nitsch R.M., and de Quervain D.J. The prion gene is associated with human long-term memory. Hum Mol Genet 14 (2005) 2241-2246
105. Pauly P.C., and Harris D.A. Copper stimulates endocytosis of the prion protein. J Biol Chem 273 (1998) 33107-33110
106. Perera W.S., and Hooper N.M. Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region. Curr Biol 11 (2001) 519-523
107. Peters P.J., Mironov Jr. A., Peretz D., van Donselaar E., Leclerc E., Erpel S., et al. Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J Cell Biol 162 (2003) 703-717
108. Prado M.A., Alves-Silva J., Magalhaes A.C., Prado V.F., Linden R., Martins V.R., et al. PrPc on the road: trafficking of the cellular prion protein. J Neurochem 88 (2004) 769-781
109. Priola S.A. Prion protein and species barriers in the transmissible spongiform encephalopathies. Biomed Pharmacother 53 (1999) 27-33
110. Priola S.A., and Lawson V.A. Glycosylation influences cross-species formation of protease-resistant prion protein. EMBO J 20 (2001) 6692-6699
111. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 216 (1982) 136-144
112. Prusiner S.B. Creutzfeldt-Jakob disease and scrapie prions. Alzheimer Dis Assoc Disord 3 (1989) 52-78
113. Prusiner S.B. Prion encephalopathies of animals and humans. Dev Biol Stand 80 (1993) 31-44
114. Prusiner S.B., and DeArmond S.J. Prion diseases of the central nervous system. Monogr Pathol (1990) 86-122
115. Prusiner S.B., and DeArmond S.J. Molecular biology and pathology of scrapie and the prion diseases of humans. Brain Pathol 1 (1991) 297-310
116. Prusiner S.B., Groth D.F., Cochran S.P., Masiarz F.R., McKinley M.P., and Martinez H.M. Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry 19 (1980) 4883-4891
117. Prusiner S.B., Stahl N., and DeArmond S.J. Novel mechanisms of degeneration of the central nervous system-prion structure and biology. Ciba Found Symp 135 (1988) 239-260
118. Prusiner S.B., Groth D., Serban A., Koehler R., Foster D., Torchia M., et al. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci USA 90 (1993) 10608-10612
119. Purdey M. Ecosystems supporting clusters of sporadic TSEs demonstrate excesses of the radical-generating divalent cation manganese and deficiencies of antioxidant co factors Cu, Se, Fe, Zn. Does a foreign cation substitution at prion protein's Cu domain initiate TSE?. Med Hypotheses 54 (2000) 278-306
120. Purdey M. Elevated silver, barium and strontium in antlers, vegetation and soils sourced from CWD cluster areas: do Ag/Ba/Sr piezoelectric crystals represent the transmissible pathogenic agent in TSEs?. Med Hypotheses 63 (2004) 211-225
121. Quaglio E., Chiesa R., and Harris D.A. Copper converts the cellular prion protein into a protease-resistant species that is distinct from the scrapie isoform. J Biol Chem 276 (2001) 11432-11438
122. Rachidi W., Vilette D., Guiraud P., Arlotto M., Riondel J., Laude H., et al. Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J Biol Chem 278 (2003) 9064-9072
123. Reder A.T., Mednick A.S., Brown P., Spire J.P., Van Cauter E., Wollmann R.L., et al. Clinical and genetic studies of fatal familial insomnia. Neurology 45 (1995) 1068-1075
124. Reilly C.E. Non-pathogenic prion protein (PrPc) acts as a cell-surface signal transducer. J Neurol 247 (2000) 819-820
125. Renner C., Fiori S., Fiorino F., Landgraf D., Deluca D., Mentler M., et al. Micellar environments induce structuring of the N-terminal tail of the prion protein. Biopolymers 73 (2004) 421-433
126. Ricketts M.N., and Brown P. Transmissible spongiform encephalopathy update and implications for blood safety. Clin Lab Med 23 (2003) 129-137
127. Roucou X., Guo Q., Zhang Y., Goodyer C.G., and LeBlanc A.C. Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J Biol Chem 278 (2003) 40877-40881
128. Sakudo A., Lee D.C., Yoshimura E., Nagasaka S., Nitta K., Saeki K., et al. Prion protein suppresses perturbation of cellular copper homeostasis under oxidative conditions. Biochem Biophys Res Commun 313 (2004) 850-855
129. Santuccione A., Sytnyk V., Leshchyns'ka I., and Schachner M. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 169 (2005) 341-354
130. Serban D., Taraboulos A., DeArmond S.J., and Prusiner S.B. Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology 40 (1990) 110-117
131. Shorter J., and Lindquist S. Prions as adaptive conduits of memory and inheritance. Nat Rev Genet 6 (2005) 435-450
132. Si K., Lindquist S., and Kandel E.R. A neuronal isoform of the aplysia CPEB has prion-like properties. Cell 115 (2003) 879-891
133. Sigurdsson E.M., Brown D.R., Alim M.A., Scholtzova H., Carp R., Meeker H.C., et al. Copper chelation delays the onset of prion disease. J Biol Chem 278 (2003) 46199-46202
134. Silburn P., Cervenakova L., Varghese P., Tannenberg A., Brown P., and Boyle R. Fatal familial insomnia: a seventh family. Neurology 47 (1996) 1326-1328
135. Stockel J., Safar J., Wallace A.C., Cohen F.E., and Prusiner S.B. Prion protein selectively binds copper (II) ions. Biochemistry 37 (1998) 7185-7193
136. Stuermer C.A., and Plattner H. The 'lipid raft' microdomain proteins reggie-1 and reggie-2 (flotillins) are scaffolds for protein interaction and signalling. Biochem Soc Symp (2005) 109-118
137. Supattapone S., Bosque P., Muramoto T., Wille H., Aagaard C., Peretz D., et al. Prion protein of 106 residues creates an artificial transmission barrier for prion replication in transgenic mice. Cell 96 (1999) 869-878
138. Tateishi J., Brown P., Kitamoto T., Hoque Z.M., Roos R., Wollman R., et al. First experimental transmission of fatal familial insomnia. Nature 376 (1995) 434-435
139. Telling G.C., Scott M., Mastrianni J., Gabizon R., Torchia M., Cohen F.E., et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83 (1995) 79-90
140. Telling G.C., Parchi P., DeArmond S.J., Cortelli P., Montagna P., Gabizon R., et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274 (1996) 2079-2082
141. Thackray A.M., Knight R., Haswell S.J., Bujdoso R., and Brown D.R. Metal imbalance and compromised antioxidant function are early changes in prion disease. Biochem J 362 (2002) 253-258
142. Todorova-Balvay D., Simon S., Creminon C., Grassi J., Srikrishnan T., and Vijayalakshmi M.A. Copper binding to prion octarepeat peptides, a combined metal chelate affinity and immunochemical approaches. J Chromatogr B Anal Technol Biomed Life Sci 818 (2005) 75-82
143. Toni M., Massimino M.L., Griffoni C., Salvato B., Tomasi V., and Spisni E. Extracellular copper ions regulate cellular prion protein (PrPC) expression and metabolism in neuronal cells. FEBS Lett 579 (2005) 741-744
144. Turk E., Teplow D.B., Hood L.E., and Prusiner S.B. Purification and properties of the cellular and scrapie hamster prion proteins. Eur J Biochem 176 (1988) 21-30
145. Varela-Nallar L., Toledo E.M., Larrondo L.F., Cabral A.L., Martins V.R., and Inestrosa N.C. Induction of cellular prion protein (PrPC) gene expression by copper in neurons. Am J Physiol Cell Physiol (2005)
146. Viles J.H., Cohen F.E., Prusiner S.B., Goodin D.B., Wright P.E., and Dyson H. Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc Natl Acad Sci USA 96 (1999) 2042-2047
147. Viles J.H., Donne D., Kroon G., Prusiner S.B., Cohen F.E., Dyson H.J., et al. Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics. Biochemistry 40 (2001) 2743-2753
148. Wechselberger C., Wurm S., Pfarr W., and Hoglinger O. The physiological functions of prion protein. Exp Cell Res 281 (2002) 1-8
149. Westaway D., Carlson G.A., and Prusiner S.B. On safari with PrP: prion diseases of animals. Trends Microbiol 3 (1995) 141-147
150. Whittal R.M., Ball H.L., Cohen F.E., Burlingame A.L., Prusiner S.B., and Baldwin M.A. Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry. Protein Sci 9 (2000) 332-343
151. Williams E.S., and Young S. Spongiform encephalopathies in Cervidae. Rev Sci Tech 11 (1992) 551-567
152. Wong B.S., Pan T., Liu T., Li R., Petersen R.B., Jones I.M., et al. Sy MS Prion disease: a loss of antioxidant function?. Biochem Biophys Res Commun 275 (2000) 249-252
153. Wong B.S., Brown D.R., Pan T., Whiteman M., Liu T., Bu X., et al. Sy MS Oxidative impairment in scrapie-infected mice is associated with brain metals perturbations and altered antioxidant activities. J Neurochem 79 (2001) 689-698
154. Wysokinska Z. Metal trace elements and their role in the animal organism. Postepy Hig Med Dosw 18 (1964) 593-611
155. Yakovleva O., Janiak A., McKenzie C., McShane L., Brown P., and Cervenakova L. Effect of protease treatment on plasma infectivity in variant Creutzfeldt-Jakob disease mice. Transfusion 44 (2004) 1700-1705
156. Yin S.M., Zheng Y., and Tien P. On-column purification and refolding of recombinant bovine prion protein: using its octarepeat sequences as a natural affinity tag. Protein Expres Purif 32 (2003) 104-109
157. Zanata S.M., Lopes M.H., Mercadante A.F., Hajj G.N., Chiarini L.B., Nomizo R., et al. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 21 (2002) 3307-3316
158. Zobeley E., Flechsig E., Cozzio A., Enari M., and Weissmann C. Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 5 (1999) 240-243